Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872304 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusion: Concurrent capecitabine and radiation therapy is well-tolerated and demonstrates promising efficacy in urothelial carcinoma, thus offering a tolerable therapeutic option in elderly patients or those with impaired performance status.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bhaumik M.D., Jeffrey M.D., Joseph M.D., Ph.D., Arthur M.D., Edson M.D., Ulka M.D.,